Anand Shah
@drAnand_Shah_
Followers
692
Following
2K
Media
99
Statuses
1K
Lung infection doctor, fungal immunology academic and dad to two little monkeys
London, England
Joined September 2015
Out Now! FungAMR: a comprehensive database for investigating fungal mutations associated with antimicrobial resistance https://t.co/WlGXyMHj7u
#FungalResearch #AntimicrobialResistance #Mycology
0
80
222
🚨 Postdoc position working with myself and @drAnand_Shah_ on Bronchiectasis innate immunity. If interested and wish to discuss further please email or DM. https://t.co/3YgrRh2Vo7 Grateful for retweet.
0
19
20
🚨 Tonight! 🚨 The next instalment of ERS Vision Live will feature an expert panel discussing antimicrobial resistance. 📅 16 June (18:00–19:00 CEST) 📍 Online Register your free place: https://t.co/xu3URkCcew
#antimicrobialresistance #AMR #bronchiectasis #cysticfibrosis
0
2
4
Climate change: shifting boundaries of fungal disease in Europe and beyond. @NormanRhijn @SarahSedik
https://t.co/rOBSkQVJHV
0
9
20
Great work, so far the largest series on biologics efficacy in #ABPA specifically. 65% response rate in treatment dependent asthma. @MFT_NAC
Pleased to share our paper of the largest real-world cohort assessing effectiveness of biologic therapy in allergic bronchopulmonary aspergillosis #aspergillus #bronchiectasis @AspergillosisT @ImperialInfect @ImperialFungal
0
3
8
Pleased to share our paper of the largest real-world cohort assessing effectiveness of biologic therapy in allergic bronchopulmonary aspergillosis #aspergillus #bronchiectasis @AspergillosisT @ImperialInfect @ImperialFungal
jaci-inpractice.org
Allergic bronchopulmonary aspergillosis (ABPA) is characterized by a severe hypersensitivity reaction to Aspergillus species. Current treatment relies on oral corticosteroids (OCS) and triazole...
1
5
26
A new month a new publication! Check out our latest paper in which we highlight a role for increased NFAT and NFκB signalling in the hyperinflammatory response to Aspergillus in cystic fibrosis 🍄 @DArmstrongJames @ImperialInfect
https://t.co/URptKCAa1c
journals.plos.org
Author summary The airways of people with cystic fibrosis (pwCF) are commonly colonised with Aspergillus fumigatus (Af) resulting in a persistent hyperinflammatory state and the development of...
0
5
10
Just published: our open-access paper showing results of a global survey of healthcare worker views on antimicrobial resistance in lung disease Pleased to help lead this research with @drAnand_Shah_ on behalf of the @EuroRespSoc @Amr_Lung CRC https://t.co/74J5vZQggC
0
1
10
Happy to share our new publication exploring how Interferon-gamma rescues dendritic cell calcineurin-dependent responses to Aspergillus fumigatus via Stat3 to Stat1 switching @DArmstrongJames @ProfAnnaReed @ImperialInfect #Aspergillus 🍄 #Immunotherapy
https://t.co/FfduLVxev7
cell.com
Pathophysiology; Microbiology; Transcriptomics
0
9
21
🚨We are looking for a motivated Research Technician to work on bronchiectasis with myself, @drAnand_Shah_ + excellent team of clinical and non-clinical researchers. Post funded by @The_MRC Details here: https://t.co/5SdoMrKWjr …. Deadline 18th Feb 2025. Pls share and retweet!
0
10
13
In the latest ERJ Podcast episode, listen as Chief Editor @ProfJDChalmers speaks to editorial board member Sanjay Chotirmall about articles published in the current issue: https://t.co/y2Qpxklxnp
0
7
15
Recruitment for @NACincas progressing; expected to continue until mid 2026. Patients starting azoles for #CPA may be eligible to be randomised to interferon gamma vs standard of care @MFT_NAC @BTSrespiratory @NIHRresearch #immunotherapy @drAnand_Shah_ @drdavidc
If you're an #NHS #respiratory doctor who manages patients with chronic #pulmonary #aspergillosis then please get in touch with @Ckosmidis (or inbox this account) to help us recruit for @NACincas 💉NCT05653193 - #NIHRfunded - Ph2 RCT ➡️More info: https://t.co/XjKqPV3FXM
0
5
7
ERJ: Fungal lung disease occurs independently or complicates underlying lung disease. Type and severity are determined by host immunity, geography and environment. Next-generation sequencing is revolutionising diagnostic and treatment strategies. https://t.co/XbTpzsbGM4
2
30
85
Just published: review of mortality in CPA analysing series from multiple countries. Mortality highest in the first year after diagnosis at 15%, and 32% at 5 years. Early recognition and treatment essential. @MFT_NAC @TheLancetInfDis #cpa
https://t.co/oDQiBdDnsW
thelancet.com
CPA is associated with substantial mortality. Advancing age, CPA subtype, and underlying comorbidities are important predictors of mortality. Future studies should focus on identifying appropriate...
1
7
17
🚨#RTI2025 Deadline Extended to November 18!🚨 Submit your abstract and join leading experts in Glasgow. Share your insights and help shape the future of respiratory health! 🌟New deadline: November 18 🔗Submit now: https://t.co/Z7pVYd5QCi
#CallForAbstracts #RespiratoryResearch
0
7
11
There is an exciting opportunity for a Clinical Research Fellow to take part in a wide range of ongoing research as part of the Infectious Diseases Clinical Research Team at St Mary’s Hospital. Apply below: https://t.co/PTlfKFAOti
@ImperialNHS @ImperialBRC
0
4
6
Getting ready to hear the best way to pursue a career in fungal research with @DArmstrongJames 🍄 🔬 @ImperialInfect @imperialcollege #Fungi #Immunology
0
4
15
Really excited about this project, come and join us in Liverpool to work on new treatments for NETS in Bronchiectasis #respisbest #ers #embarc #bronchuk
I have a fully funded MRC DiMeN PhD project available for 2025, working with #neutrophils #NETs #proteomics to identify new treatments for #bronchiectasis - with @Freddy_Frost1 @emmottlab @LivNeutrophil based in @LivuniILCaMS Details ⬇️ https://t.co/HUt3nw0REq
0
4
9
First participants recruited into the INCAS study at @MFT_Research ! Randomised trial of interferon gamma in chronic pulmonary aspergillosis. More info here: https://t.co/nePAVGbBmp
@NACincas @MFT_NAC @NIHRresearch #CPA @RBazaz @drAnand_Shah_
3
5
18
Asthma: Moderate/high dose inhaled steroids - uncommonly - cause CVD, pneumonia and PEs. V difficult study to do to avoid bias. Required 2 large datasets and multiple different studies. Patients should only get the ICS dose they need! @Azeem_Majeed
https://t.co/CGy3JZFdzt
2
9
14